"We're also closely monitoring potential future shortages, as Novo Nordisk stated two weeks ago that it would continue to have 'capacity limitations' and 'expected continued periodic supply constraints and related drug shortage notifications.'" Him & Hers' weight loss offerings have been a massive hit with investors
Cagrilintide has a place, particularly in combination protocols like CagriSema or for individuals who respond better to amylin-based interventions
Acknowledgments All the pictures in this article are drawn in Adobe Illustrator 2023, thanks to the support provided by the software
These findings position the entero-gustatory-endocrine axis as a therapeutic target in metabolic disorders, where GLP-1 dysfunction disrupts taste signaling, perpetuating pathological feeding behaviors ( Figure 3 )
Pharmaceutics 13 , 500 (2021)
Not every product is appropriate for all, however, and those with other ailments or medications should exercise caution